您好,欢迎来到海南中小企业大数据中心及公共服务平台!     请登录   免费注册
专利概况
专利名称 METHODS OF USING A GIP/GLP1 CO-AGONIST FOR THERAPY
申请号 WOUS19042817 申请日
公开(公告)号 WO2020023382A1 公开(公告)日
申请(专利权)人 ELI LILLY AND COMPANY 发明人 BENSON Charles T; HAUPT Axel; THOMAS Melissa Kay; URVA Shweta
专利来源 国家知识产权局 转化方式
摘要

The present invention provides a method for increasing glycemic control in a patient in need thereof, by administering tirzepatide, or a pharmaceutically acceptable salt thereof. The present invention provides a method for improving weight management in a patient in need thereof, by administering tirzepatide, or a pharmaceutically acceptable salt thereof. Further providing a method for treating a condition selected from atherosclerosis, chronic kidney disease, NAFLD, and NASH. Further provided is a method to prevent or induce remission of diabetes comprising administration of tirzepatide, or a pharmaceutically acceptable salt thereof. Further provided is a dosing regimen for increasing glycemic control, improving weight management, and/or treating dyslipidemia.

参与列表

主管部门:海南中小企业服务 | 建设单位:海南商业联合会

版权所有:海南商业联合会 | 备案号:粤ICP备13083911号(ICP加挂服务)@2017